Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$38.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 10 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 249 business days late.
The 30 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Sep 24 | MNPR | Monopar Therapeutics | SSELL◷ | 600 | $89.79 | $53.9K | -0.6% | Open the original filing on SEC.gov |
| Sep 24 | MNPR | Monopar Therapeutics | SSELL◷ | 8,368 | $88.97 | $744.5K | -7.7% | Open the original filing on SEC.gov |
| Sep 24 | MNPR | Monopar Therapeutics | SSELL◷ | 9,638 | $87.96 | $847.8K | -8.2% | Open the original filing on SEC.gov |
| Sep 24 | MNPR | Monopar Therapeutics | SSELL◷ | 10,450 | $87.15 | $910.7K | -8.1% | Open the original filing on SEC.gov |
| Sep 24 | MNPR | Monopar Therapeutics | MEXER◷ | 15,000 | $14.00 | $210K | +13.2% | Open the original filing on SEC.gov |
| Sep 24 | MNPR | Monopar Therapeutics | MEXER◷ | 14,056 | $30.00 | $421.7K | +14.2% | Open the original filing on SEC.gov |
| Jun 30 | MNPR | Monopar Therapeutics | MEXER◆ | 12,873 | — | — | — | Open the original filing on SEC.gov |
| Jun 30 | MNPR | Monopar Therapeutics | FTAX | 4,084 | $92.59 | $378.1K | -4.0% | Open the original filing on SEC.gov |
| Jun 30 | MNPR | Monopar Therapeutics | MEXER | 12,873 | — | — | +14.2% | Open the original filing on SEC.gov |
| Mar 31 | MNPR | Monopar Therapeutics | MEXER◆ | 6,732 | — | — | — | Open the original filing on SEC.gov |
| Mar 31 | MNPR | Monopar Therapeutics | FTAX | 1,972 | $54.79 | $108K | -2.1% | Open the original filing on SEC.gov |
| Mar 31 | MNPR | Monopar Therapeutics | MEXER | 6,732 | — | — | +7.8% | Open the original filing on SEC.gov |
| Dec 31, 2025 | MNPR | Monopar Therapeutics | MEXER◆ | 8,724 | — | — | — | Open the original filing on SEC.gov |
| Dec 31, 2025 | MNPR | Monopar Therapeutics | FTAX | 2,558 | $65.30 | $167K | -2.9% | Open the original filing on SEC.gov |
| Dec 31, 2025 | MNPR | Monopar Therapeutics | MEXER | 8,724 | — | — | +11.0% | Open the original filing on SEC.gov |
| Dec 2, 2025 | MNPR | Monopar Therapeutics | AGRANT◆ | 49,133 | — | — | — | Open the original filing on SEC.gov |
| Dec 2, 2025 | MNPR | Monopar Therapeutics | AGRANT◆ | 16,753 | — | — | — | Open the original filing on SEC.gov |
| Sep 30, 2025 | MNPR | Monopar Therapeutics | MEXER◆ | 8,726 | — | — | — | Open the original filing on SEC.gov |
| Sep 30, 2025 | MNPR | Monopar Therapeutics | FTAX | 2,646 | $81.67 | $216.1K | -3.2% | Open the original filing on SEC.gov |
| Sep 30, 2025 | MNPR | Monopar Therapeutics | MEXER | 8,726 | — | — | +11.9% | Open the original filing on SEC.gov |
| Sep 24, 2025 | MNPR | Monopar Therapeutics | SSELL | 550,229 | $63.61 | $35M | -66.9% | Open the original filing on SEC.gov |
| Jul 14, 2025 | MNPR | Monopar Therapeutics | XXITM◆ | 16,800 | — | — | — | Open the original filing on SEC.gov |
| Jul 14, 2025 | MNPR | Monopar Therapeutics | SSELL | 16,800 | $40.00 | $672K | -18.6% | Open the original filing on SEC.gov |
| Jul 14, 2025 | MNPR | Monopar Therapeutics | XXITM | 16,800 | $0.005 | $84 | +22.9% | Open the original filing on SEC.gov |
| Jun 30, 2025 | MNPR | Monopar Therapeutics | MEXER◆ | 13,344 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | MNPR | Monopar Therapeutics | FTAX | 5,865 | $35.78 | $209.8K | -7.4% | Open the original filing on SEC.gov |
| Jun 30, 2025 | MNPR | Monopar Therapeutics | MEXER | 13,344 | — | — | +20.2% | Open the original filing on SEC.gov |
| Jan 28, 2025 | MNPR | Monopar Therapeutics | JOTHER | 62,815 | — | — | — | Open the original filing on SEC.gov |